Product Images Spironolactone

This text appears to show data on the subgroup level hazard ratio (HR) and 95% confidence interval (CI) for Spironolactone and Placebo. The data likely indicates the comparative effectiveness between Spironolactone and Placebo in a study or trial.*

This is a product description for Spironolactone tablets. Each film-coated tablet contains 25 mg of Spironolactone USP. The tablets are to be stored below 77°F (25°C) and protected from light. They should be dispensed in tight, light-resistant, and child-resistant containers. Prescribing information should be consulted for dosage and use instructions. The tablets are manufactured by Graviti Pharmaceuticals Pvt. Ltd. in Telangana, India, and distributed by Rising Pharma Holdings in East Brunswick, NJ. The product's label indicates an issuance date of 03/2025.*

This is information about Spironolactone tablets, containing 50mg of Spironolactone USP. The tablets are film-coated and come in a pack of 100 tablets. The dosage and usage instructions can be found in the accompanying prescribing information. These tablets should be stored below 77°F (25°C) and protected from light. They are dispensed in tight, light-resistant, child-resistant containers. The product is manufactured by Graviti Pharmaceuticals Pvt Ltd in Telangana, India, and distributed by Rising Pharma Holdings, Inc. in East Brunswick, NJ, USA. The batch was issued in March 2025.*

This is information about Spironolactone tablets USP containing 100 mg per tablet. The tablets should be stored below 77°F (25°C) and protected from light. They should be dispensed in light-resistant, child-resistant containers. The tablets are manufactured by Graviti Pharmaceuticals Pvt Ltd in Telangana, India and distributed by Rising Pharma Holdings, Inc in East Brunswick, NJ. The issuing date of the information is 03/2025. Further dosage and prescribing information can be found in the accompanying document.*